new formulations of 611
SSGJ-611-HV-I-02
Phase 1 small_molecule active
Quick answer
new formulations of 611 for Atopic Dermatitis is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Atopic Dermatitis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active